Novo Nordisk Shakeup: Boardroom Drama and Wegovy Worries

Novo Nordisk in turmoil! A boardroom shakeup at the Wegovy maker triggered a $10 billion market drop. The company's top investor is ousting the chair and six board members, replacing them with a former CEO amidst pricing pressure and rising competition from Eli Lilly. Is this a strategic reset or a sign of deeper instability? All eyes are on Novo as new leadership takes the reins.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.